Entity Common Stock, Shares Outstanding of Tarsus Pharmaceuticals, Inc. from 23 Nov 2020 to 17 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tarsus Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 23 Nov 2020 to 17 Feb 2026.
  • Tarsus Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 17 Feb 2026 was 42,557,492, a 1.3% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Tarsus Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 42,557,492 +543,255 +1.3% 17 Feb 2026 10-K 23 Feb 2026 2025 FY
Q3 2025 42,449,105 +4,222,176 +11% 29 Oct 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 42,214,106 +4,172,369 +11% 31 Jul 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 42,014,237 +4,232,544 +11% 24 Apr 2025 10-Q 01 May 2025 2025 Q1
Q3 2024 38,226,929 +5,122,317 +15% 07 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 38,041,737 +5,425,220 +17% 02 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 37,781,693 +11,050,030 +41% 02 May 2024 10-Q 08 May 2024 2024 Q1
Q3 2023 33,104,612 +6,432,424 +24% 03 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 32,616,517 +5,958,049 +22% 04 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 26,731,663 +6,022,717 +29% 09 Mar 2023 10-K 17 Mar 2023 2022 FY
Q3 2022 26,672,188 +5,995,196 +29% 07 Nov 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 26,658,468 +6,084,364 +30% 05 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 20,708,946 +205,850 +1% 09 Mar 2022 10-K 14 Mar 2022 2021 FY
Q3 2021 20,676,992 04 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 20,574,104 01 Aug 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 20,503,096 19 Mar 2021 10-K 31 Mar 2021 2020 FY
Q4 2020 20,320,426 23 Nov 2020 10-Q 25 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.